文献速递重症综合管理与镇静镇痛

预设选项对重症患者预立医疗指示选择及无住院天数的影响:一项随机临床试验

Effect of Default Options in Advance Directives on Hospital-Free Days and Care Choices Among Seriously Ill Patients: A Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2020-03-02
一句话结论在重症患者中,预立医疗指示的预设选项改变了患者对未来照护的选择,但未改变无住院天数等临床结局。

该随机临床试验纳入515例符合重症标准并同意参与的患者,来自20家门诊诊所,随机分配完成三种预立医疗指示之一:预设舒适照护(舒适AD)、预设延长生命(延长生命AD)或标准AD(无预设选项)。主要终点为无住院天数,预设选项组非劣效于标准AD组。在返回有效AD的患者中,舒适AD组选择舒适照护的比例(63.5%)高于标准AD组(49.5%)和延长生命AD组(37.5%),差异有统计学意义(P=0.001)。在改良意向治疗分析中,三组选择舒适照护的比例分别为33.9%、28.5%和22.0%(P=0.02)。其他次要结局组间无差异。预设选项改变了患者的选择,但未改变临床结局。

要点

  • 在返回有效AD的重症患者中,舒适AD组63.5%选择舒适照护,高于标准AD组的49.5%和延长生命AD组的37.5%(P=0.001)。
  • 在改良意向治疗分析的492例患者中,舒适AD组33.9%、标准AD组28.5%、延长生命AD组22.0%选择舒适照护(P=0.02)。
  • 预设舒适AD和预设延长生命AD的无住院天数均非劣效于标准AD:标准AD 486天,舒适AD 554天(率比1.05,95%CI 0.90-1.23,P<0.001),延长生命AD 550天(率比1.03,95%CI 0.88-1.20,P<0.001)。
  • 其他次要结局(生活质量、决策冲突、死亡地点、住院和ICU入住、住院费用)组间无差异。
  • 预设选项可影响重症患者预立医疗指示中的照护选择,但未改变临床结局。

适用人群与场景

  • 符合重症标准并同意参与的患者,来自20家附属于University of Pennsylvania Health System和University of Pittsburgh Medical Center的门诊诊所,入组时间2014年2月至2016年4月。
  • 改良意向治疗样本492例(95.5%),中位年龄63岁(IQR 56-70),男性279例(56.7%),黑人122例(24.8%),癌症患者363例(73.8%)。

处置流程与药物剂量

  • 患者随机完成三种预立医疗指示之一:舒适AD(预设选择舒适照护计划并拒绝可能维持生命的治疗)、延长生命AD(预设选择延长生命计划并接受可能维持生命的治疗)、标准AD(无预设选项)。

研究设计与关键结果

  • 随机临床试验,515例患者随机,10例撤回同意、13例 later 发现不符合条件,492例(95.5%)纳入改良意向治疗分析;中位随访18个月。
  • 在返回合法有效AD的264例(53.7%)中,舒适AD组54/85(63.5%)选择舒适照护,高于标准AD组45/91(49.5%)和延长生命AD组33/88(37.5%)(P=0.001)。
  • 在492例改良意向治疗分析中,舒适AD组57/168(33.9%)、标准AD组47/165(28.5%)、延长生命AD组35/159(22.0%)选择舒适照护(P=0.02),未返回AD者编码为未选择舒适照护。
  • 改良意向治疗分析中,无住院天数:标准AD组486天(IQR 306-717),舒适AD组554天(IQR 296-833),率比1.05(95%CI 0.90-1.23,P<0.001);延长生命AD组550天(IQR 325-783),率比1.03(95%CI 0.88-1.20,P<0.001);两预设选项组均非劣效于标准AD组。
  • 其他次要结局组间无差异。

证据类型、等级与局限

  • 随机临床试验;
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,预设选项在预立医疗指示中改变了重症患者对未来照护的选择,但未改变临床结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: There is limited evidence regarding how patients make choices in advance directives (ADs) or whether these choices influence subsequent care.

OBJECTIVE: To examine whether default options in ADs influence care choices and clinical outcomes.

DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial included 515 patients who met criteria for having serious illness and agreed to participate. Patients were enrolled at 20 outpatient clinics affiliated with the University of Pennsylvania Health System and the University of Pittsburgh Medical Center from February 2014 to April 2016 and had a median follow-up of 18 months. Data analysis was conducted from November 2018 to April 2019.

INTERVENTIONS: Patients were randomly assigned to complete 1 of the 3 following ADs: (1) a comfort-promoting plan of care and nonreceipt of potentially life-sustaining therapies were selected by default (comfort AD), (2) a life-extending plan of care and receipt of potentially life-sustaining therapies were selected by default (life-extending AD), or (3) no choices were preselected (standard AD).

MAIN OUTCOMES AND MEASURES: This trial was powered to rule out a reduction in hospital-free days in the intervention groups. Secondary outcomes included choices in ADs for an overall comfort-oriented approach to care, choices to forgo 4 forms of life support, patients' quality of life, decision conflict, place of death, admissions to hospitals and intensive care units, and costs of inpatient care.

RESULTS: Among 515 patients randomized, 10 withdrew consent and 13 were later found to be ineligible, leaving 492 (95.5%) in the modified intention-to-treat (mITT) sample (median [interquartile range] age, 63 [56-70] years; 279 [56.7%] men; 122 [24.8%] black; 363 [73.8%] with cancer). Of these, 264 (53.7%) returned legally valid ADs and were debriefed about their assigned intervention. Among these, patients completing comfort ADs were more likely to choose comfort care (54 of 85 [63.5%]) than those returning standard ADs (45 of 91 [49.5%]) or life-extending ADs (33 of 88 [37.5%]) (P = .001). Among 492 patients in the mITT sample, 57 of 168 patients [33.9%] who completed the comfort AD, 47 of 165 patients [28.5%] who completed the standard AD, and 35 of 159 patients [22.0%] who completed the life-extending AD chose comfort care (P = .02), with patients not returning ADs coded as not selecting comfort care. In mITT analyses, median (interquartile range) hospital-free days among 168 patients assigned to comfort ADs and 159 patients assigned to life-extending default ADs were each noninferior to those among 165 patients assigned to standard ADs (standard AD: 486 [306-717] days; comfort AD: 554 [296-833] days; rate ratio, 1.05; 95% CI, 0.90-1.23; P < .001; life-extending AD: 550 [325-783] days; rate ratio, 1.03; 95% CI, 0.88-1.20; P < .001). There were no differences among groups in other secondary outcomes.

CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, default options in ADs altered the choices seriously ill patients made regarding their future care without changing clinical outcomes.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02017548.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Halpern SD, Small DS, Troxel AB, et al. Effect of Default Options in Advance Directives on Hospital-Free Days and Care Choices Among Seriously Ill Patients: A Randomized Clinical Trial. JAMA Netw Open. 2020. PMID: 32227179. doi:10.1001/jamanetworkopen.2020.1742

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。